Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionEquitable Holdings, Inc.
Latest Disclosed Ownership101,366 shares
Latest Disclosed Value $ 12,606,624
Equitable Holdings, Inc. reports 6.97% increase in ownership of GILD / Gilead Sciences, Inc.

On May 15, 2026 - Equitable Holdings, Inc. filed a 13F-HR form disclosing ownership of 101,366 shares of Gilead Sciences, Inc. (CH:GILD) valued at $12,606,624 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 94,759 shares of Gilead Sciences, Inc.. This represents a change in shares of 6.97% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 101,366 6,607 6.97 12,607 8.39 0.0811
2026-02-17 2025-12-31 13F GILEAD SCIENCES COM 375558103 94,759 4,006 4.41 11,631 15.46 0.0795
2025-11-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 90,753 -2,174 -2.34 10,074 -2.22 0.0741
2025-08-15 2025-06-30 13F GILEAD SCIENCES COM 375558103 92,927 4,415 4.99 10,303 3.88 0.0849
2025-05-13 2025-03-31 13F GILEAD SCIENCES COM 375558103 88,512 2,728 3.18 9,918 25.17 0.0941
2025-02-12 2024-12-31 13F GILEAD SCIENCES COM 375558103 85,784 -683 -0.79 7,924 9.30 0.0754
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 86,467 22,560 35.30 7,249 65.35 0.0702
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 63,907 1,427 2.28 4,385 -4.20 0.0461
2024-05-14 2024-03-31 13F GILEAD SCIENCES COM 375558103 62,480 405 0.65 4,577 -8.99 0.0515
2024-02-13 2023-12-31 13F GILEAD SCIENCES COM 375558103 62,075 518 0.84 5,029 9.00 0.0620
2023-11-14 2023-09-30 13F GILEAD SCIENCES COM 375558103 61,557 2,090 3.51 4,613 0.65 0.0662
2023-08-15 2023-06-30 13F GILEAD SCIENCES COM 375558103 59,467 4,024 7.26 4,583 -0.37 0.0659
2023-05-15 2023-03-31 13F GILEAD SCIENCES COM 375558103 55,443 6,656 13.64 4,600 9.84 0.0735
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 48,787 763 1.59 4,188 41.34 0.0729
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 48,024 -204 -0.42 2,963 -0.60 0.0579
2022-08-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 48,228 520 1.09 2,981 5.11 0.0569
2022-05-13 2022-03-31 13F GILEAD SCIENCES COM 375558103 47,708 6,864 16.81 2,836 -4.38 0.0464
2022-02-11 2021-12-31 13F GILEAD SCIENCES COM 375558103 40,844 -409 -0.99 2,966 2.91 0.0467
2021-11-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 41,253 156 0.38 2,882 1.84 0.0492
2021-08-11 2021-06-30 13F GILEAD SCIENCES COM 375558103 41,097 599 1.48 2,830 8.14 0.0488
2021-05-14 2021-03-31 13F GILEAD SCIENCES COM 375558103 40,498 5,797 16.71 2,617 29.43 0.0553
2021-02-09 2020-12-31 13F GILEAD SCIENCES COM 375558103 34,701 -1,003 -2.81 2,022 -10.37 0.0460
2020-11-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 35,704 1,535 4.49 2,256 -14.19 0.0582
2020-08-13 2020-06-30 13F GILEAD SCIENCES COM 375558103 34,169 -1,141 -3.23 2,629 -0.42 0.0757
2020-05-15 2020-03-31 13F GILEAD SCIENCES COM 375558103 35,310 1,940 5.81 2,640 21.77 0.0948
2020-05-28 2019-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 33,370 33,370 2,168 0.0633
2020-02-18 2019-12-31 13F GILEAD SCIENCES COM 375558103 33,370 2,168 0.0113
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.